DE60329226D1 - Verfahren zur unterdrückung einer immunsystemreaktion gegen gewebe- oder zelltransplantate - Google Patents
Verfahren zur unterdrückung einer immunsystemreaktion gegen gewebe- oder zelltransplantateInfo
- Publication number
- DE60329226D1 DE60329226D1 DE60329226T DE60329226T DE60329226D1 DE 60329226 D1 DE60329226 D1 DE 60329226D1 DE 60329226 T DE60329226 T DE 60329226T DE 60329226 T DE60329226 T DE 60329226T DE 60329226 D1 DE60329226 D1 DE 60329226D1
- Authority
- DE
- Germany
- Prior art keywords
- dendritic cells
- transplant
- intended
- blood
- immune system
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title abstract 3
- 210000000987 immune system Anatomy 0.000 title 1
- 210000004443 dendritic cell Anatomy 0.000 abstract 7
- 210000004369 blood Anatomy 0.000 abstract 3
- 239000008280 blood Substances 0.000 abstract 3
- 208000009329 Graft vs Host Disease Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 208000024908 graft versus host disease Diseases 0.000 abstract 1
- 230000000899 immune system response Effects 0.000 abstract 1
- 230000035800 maturation Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 210000001616 monocyte Anatomy 0.000 abstract 1
- 230000001629 suppression Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/001—Preparations to induce tolerance to non-self, e.g. prior to transplantation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4615—Dendritic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
- A61K39/4621—Cellular immunotherapy characterized by the effect or the function of the cells immunosuppressive or immunotolerising
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
- A61K39/4622—Antigen presenting cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/46434—Antigens related to induction of tolerance to non-self
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0639—Dendritic cells, e.g. Langherhans cells in the epidermis
- C12N5/064—Immunosuppressive dendritic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5158—Antigen-pulsed cells, e.g. T-cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Heart & Thoracic Surgery (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Vascular Medicine (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Transplantation (AREA)
- Endocrinology (AREA)
- Pathology (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Cardiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/290,802 US7727523B2 (en) | 2001-08-13 | 2002-11-08 | Method for suppressing immune system response to transplanted tissue or cells |
PCT/US2003/035509 WO2004044149A2 (en) | 2002-11-08 | 2003-11-07 | Method for suppressing immune system response to transplanted tissue or cells |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60329226D1 true DE60329226D1 (de) | 2009-10-22 |
Family
ID=32312118
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60329226T Expired - Lifetime DE60329226D1 (de) | 2002-11-08 | 2003-11-07 | Verfahren zur unterdrückung einer immunsystemreaktion gegen gewebe- oder zelltransplantate |
Country Status (8)
Country | Link |
---|---|
US (2) | US7727523B2 (de) |
EP (2) | EP2135942B1 (de) |
AT (1) | ATE442434T1 (de) |
AU (2) | AU2003290641B2 (de) |
CA (1) | CA2505527C (de) |
DE (1) | DE60329226D1 (de) |
ES (2) | ES2392842T3 (de) |
WO (1) | WO2004044149A2 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7727523B2 (en) * | 2001-08-13 | 2010-06-01 | Yale University | Method for suppressing immune system response to transplanted tissue or cells |
ATE454895T1 (de) * | 2001-08-13 | 2010-01-15 | Univ Yale | Verfahren zur induktion einer selektiv unterdrückten immunantwort |
WO2005027841A2 (en) * | 2003-09-16 | 2005-03-31 | University Of North Carolina At Chapel Hill | Cells, compositions and methods for repressing b cell autoantibody secretion and for treating autoimmune disease |
CA2628341A1 (en) | 2005-11-02 | 2007-05-18 | Therakos Inc. | The use of apoptotic cells ex vivo to generate regulatory t cells |
US8524495B2 (en) | 2007-05-16 | 2013-09-03 | Yale University | Methods for inducing the differentiation of blood monocytes into functional dendritic cells |
WO2010000730A1 (en) * | 2008-06-30 | 2010-01-07 | Universitätsklinikum Heidelberg | Immunosuppressive blood cells and methods of producing same |
US9399093B2 (en) | 2012-01-27 | 2016-07-26 | Fenwal, Inc. | Systems and methods for performing online extracorporeal photopheresis |
GB201300049D0 (en) * | 2013-01-03 | 2013-02-20 | Transimmune Ag | Method for obtaining immuno-stimulatory dendritic cells |
GB201413665D0 (en) | 2014-07-03 | 2014-09-17 | Transimmune Ag And Yale University | Method for obtaining globally activated monocytes |
US10434240B2 (en) | 2015-08-17 | 2019-10-08 | Fenwal, Inc. | Methods and systems for processing and washing a photopheresis mononuclear cell product |
CN113826014A (zh) * | 2019-04-16 | 2021-12-21 | 明尼苏达大学董事会 | 由凋亡供体白细胞诱导的移植耐受性的生物标志物 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4321918A (en) * | 1979-10-23 | 1982-03-30 | Clark Ii William T | Process for suppressing immunity to transplants |
US4838852A (en) * | 1987-03-27 | 1989-06-13 | Therakos, Inc. | Active specific immune suppression |
CA2249412A1 (en) | 1996-03-22 | 1997-09-25 | Yale University | Methods for inducing immune responsiveness in a subject |
WO1999042564A2 (en) * | 1998-02-20 | 1999-08-26 | The Rockefeller University | Apoptotic cell-mediated antigen presentation to dendritic cells |
US6596275B1 (en) * | 1998-03-30 | 2003-07-22 | I.D.M. Immuno-Designed Molecules | Monocyte derived cells with immunosuppressive properties, process for their preparation and their uses in pharmaceutical compositions |
US6540367B1 (en) * | 1999-04-07 | 2003-04-01 | 3M Innovative Properties Company | Structured surface articles containing geometric structures with compound faces and methods for making same |
US20050084966A1 (en) * | 1999-04-20 | 2005-04-21 | Edelson Richard L. | Methods for inducing the differentiation of blood monocytes into functional dendritic cells |
CA2368855C (en) * | 1999-04-20 | 2012-05-29 | Richard Leslie Edelson | Differentiation of monocytes into functional dendritic cells |
US7560105B1 (en) * | 1999-10-04 | 2009-07-14 | Leids Universitair Medisch Centrum | Dendritic cells activated in the presence of glucocorticoid hormones are capable of suppressing antigen-specific T cell responses |
US6800300B1 (en) * | 2000-03-31 | 2004-10-05 | Vasogen Ireland Limited | Method for treating autoimmune and alloimmune diseases |
WO2001077299A2 (en) * | 2000-04-11 | 2001-10-18 | University Of Southern California | A METHOD TO PREVENT GRAFT REJECTION USING TGF-β TO INDUCE T SUPPRESSOR CELLS |
CA2309518A1 (en) * | 2000-05-25 | 2001-11-25 | Vasogen Ireland Limited | Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders |
US20050013810A1 (en) * | 2001-05-08 | 2005-01-20 | Waller Edmund K | Regulating immune response using dendritic cells |
US7727523B2 (en) * | 2001-08-13 | 2010-06-01 | Yale University | Method for suppressing immune system response to transplanted tissue or cells |
AU2007200894B2 (en) * | 2001-08-13 | 2009-10-29 | Yale University | Method for inducing selectively suppressed immune response |
ATE454895T1 (de) * | 2001-08-13 | 2010-01-15 | Univ Yale | Verfahren zur induktion einer selektiv unterdrückten immunantwort |
US6602102B2 (en) | 2001-10-10 | 2003-08-05 | South Valley Specialties | Buoyant silicone rubber compound |
-
2002
- 2002-11-08 US US10/290,802 patent/US7727523B2/en active Active
-
2003
- 2003-11-07 ES ES09169782T patent/ES2392842T3/es not_active Expired - Lifetime
- 2003-11-07 AT AT03783222T patent/ATE442434T1/de not_active IP Right Cessation
- 2003-11-07 EP EP09169782A patent/EP2135942B1/de not_active Expired - Lifetime
- 2003-11-07 EP EP03783222A patent/EP1578958B1/de not_active Expired - Lifetime
- 2003-11-07 WO PCT/US2003/035509 patent/WO2004044149A2/en not_active Application Discontinuation
- 2003-11-07 DE DE60329226T patent/DE60329226D1/de not_active Expired - Lifetime
- 2003-11-07 ES ES03783222T patent/ES2334501T3/es not_active Expired - Lifetime
- 2003-11-07 CA CA2505527A patent/CA2505527C/en not_active Expired - Lifetime
- 2003-11-07 AU AU2003290641A patent/AU2003290641B2/en not_active Expired
-
2010
- 2010-05-04 US US12/773,141 patent/US8231868B2/en not_active Expired - Lifetime
- 2010-07-23 AU AU2010203292A patent/AU2010203292B2/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
WO2004044149A3 (en) | 2004-07-15 |
US7727523B2 (en) | 2010-06-01 |
ES2392842T3 (es) | 2012-12-14 |
EP2135942A1 (de) | 2009-12-23 |
AU2010203292A1 (en) | 2010-08-12 |
WO2004044149A2 (en) | 2004-05-27 |
AU2010203292B2 (en) | 2011-07-28 |
EP1578958A4 (de) | 2006-03-22 |
EP2135942B1 (de) | 2012-08-08 |
CA2505527A1 (en) | 2004-05-27 |
AU2003290641A1 (en) | 2004-06-03 |
US20030133914A1 (en) | 2003-07-17 |
ES2334501T3 (es) | 2010-03-11 |
CA2505527C (en) | 2012-03-13 |
EP1578958A2 (de) | 2005-09-28 |
ATE442434T1 (de) | 2009-09-15 |
US8231868B2 (en) | 2012-07-31 |
EP1578958B1 (de) | 2009-09-09 |
AU2003290641B2 (en) | 2010-05-27 |
US20100209409A1 (en) | 2010-08-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE493492T1 (de) | Verfahren und system zur herstellung von stammzellen aus fettgewebe | |
DE60329226D1 (de) | Verfahren zur unterdrückung einer immunsystemreaktion gegen gewebe- oder zelltransplantate | |
ATE455463T1 (de) | Verfahren zur herstellung gefriergetrockneter blutplättchen, gefriergetrocknete blutplättchen enthaltende zusammensetzungen und verwendungsverfahren | |
MXPA02007137A (es) | Fuente de tejido hepatico. | |
DK1294414T3 (da) | Præparat og fremgangsmåde til heling og regenerering af brusk og andre væv | |
ATE413182T1 (de) | Gerät und verfahren zur herstellung von stabilem langzeitigem thrombin aus plasma sowie so hergestelltes thrombin | |
WO2009007531A3 (fr) | Support collagenique modifie par greffage covalent de molecules d'adhesion | |
WO1998020932A3 (en) | Conditioning for allogeneic stem cell transplantation | |
JP2018537472A (ja) | 増殖造血幹細胞/前駆細胞集団の利用 | |
WO2003085092A3 (en) | Cellular transplantation for heart regeneration | |
ATE300310T1 (de) | Verfahren zur steigerung von hematopoietischen zellen | |
BR9612821A (pt) | Métodos para a prevenção de rejeição de enxerto em transplante e para a produção de uma célula de hospedeiro para terapia genética universal | |
WO2005047469A3 (en) | PORCINE ISOGLOBOSIDE 3 SYNTHASE PROTEIN, cDNA, GENOMIC ORGANIZATION, AND REGULATORY REGION | |
WO2004011631A3 (en) | Methods and compositions for treating tissue defects using pulsed electromagnetic field stimulus | |
Duran-Struuck et al. | Miniature swine as a clinically relevant model of graft-versus-host disease | |
WO2010033598A3 (en) | System and method for utilizing microbubbles and liposomes as viral sequestering agents | |
US20160120909A1 (en) | Compositions And Methods For The Treatment Of Tinnitus | |
US20080290050A1 (en) | Device, Kit to Filter Bone Marrow Aspirate | |
WO2005041877A3 (en) | Method of inhibiting rejection following organ transplantation | |
WO2005109199A3 (en) | Method for selectively expanding, selecting and enriching stem/progenitor cell populations | |
Chen et al. | A possible contribution of retinoids to regulation of fetal B lymphopoiesis | |
WO2004052305A3 (en) | Lactoferrin as an agent in the prevention of organ transplant rejection and graft-versus-host-disease | |
EP1815856A3 (de) | Krebsimpfstoff | |
CN101837014A (zh) | 用于治疗慢性肾脏疾病之医药组合物 | |
EP1728857A3 (de) | Bereitstellung von Lebergewebe. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |